Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer

High-grade serous ovarian carcinomas (HGSOCs) with BRCA1/2 mutations exhibit improved outcome and sensitivity to double-strand DNA break (DSB)-inducing agents (i.e., platinum and poly(ADP-ribose) polymerase inhibitors [PARPis]) due to an underlying defect in homologous recombination (HR). However, r...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cell reports (Cambridge) Ročník 14; číslo 3; s. 429 - 439
Hlavní autori:	Choi, Young Eun, Meghani, Khyati, Brault, Marie-Eve, Leclerc, Lucas, He, Yizhou J., Day, Tovah A., Elias, Kevin M., Drapkin, Ronny, Weinstock, David M., Dao, Fanny, Shih, Karin K., Matulonis, Ursula, Levine, Douglas A., Konstantinopoulos, Panagiotis A., Chowdhury, Dipanjan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 26.01.2016 Elsevier
Predmet:	Animals Antigens, Nuclear - genetics Antigens, Nuclear - metabolism Antineoplastic Agents - pharmacology Base Sequence BRCA1 Protein - genetics BRCA1 Protein - metabolism Cell Line, Tumor Disease-Free Survival DNA End-Joining Repair - drug effects DNA-Binding Proteins - antagonists & inhibitors DNA-Binding Proteins - genetics DNA-Binding Proteins - metabolism Female Homologous Recombination - drug effects Humans Intracellular Signaling Peptides and Proteins - genetics Intracellular Signaling Peptides and Proteins - metabolism Ku Autoantigen Mice MicroRNAs - antagonists & inhibitors MicroRNAs - genetics MicroRNAs - metabolism Oligonucleotides, Antisense - metabolism Organoplatinum Compounds - pharmacology Ovarian Neoplasms - genetics Ovarian Neoplasms - mortality Ovarian Neoplasms - pathology Poly(ADP-ribose) Polymerase Inhibitors - pharmacology RNA Interference Sequence Alignment Tumor Suppressor p53-Binding Protein 1
ISSN:	2211-1247, 2211-1247
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!